Login
$TNGX
$24.22 +$0.05 (0.21%) After hours

Insider Transactions

What Tango Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 11 30
Total trades 15 53

Shares traded

3 months 12 months
Acquired 64,000 809,382
Disposed 79,231 398,575
Net activity −15,231 +410,807

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Crystal Adam President, R&D Nov 11 Open-market sale · S −5,000 $25.00 −$125K 115,743
Crystal Adam President, R&D Nov 11 Exercise / conversion · M +5,000 $2.91 +$14.6K 120,743
Crystal Adam President, R&D Nov 02 Open-market sale · S −1,100 $22.99 −$25.3K 115,743
Crystal Adam President, R&D Nov 02 Open-market sale · S −3,900 $22.26 −$86.8K 116,843
Crystal Adam President, R&D Nov 02 Exercise / conversion · M +5,000 $2.91 +$14.6K 120,743
Newcomb Jessica Principal Accounting Officer Nov 02 Open-market sale · S −1,460 $22.98 −$33.6K 52,090
Newcomb Jessica Principal Accounting Officer Nov 02 Open-market sale · S −5,571 $22.28 −$124K 53,550
Crystal Adam President, R&D Oct 01 Open-market sale · S −600 $25.32 −$15.2K 115,743
Crystal Adam President, R&D Oct 01 Open-market sale · S −26,400 $24.45 −$646K 116,343
Crystal Adam President, R&D Oct 01 Exercise / conversion · M +27,000 $5.20 +$140K 142,743
Newcomb Jessica Principal Accounting Officer Sep 22 Open-market sale · S −2,400 $25.17 −$60.4K 59,121
Newcomb Jessica Principal Accounting Officer Sep 22 Open-market sale · S −5,100 $23.97 −$122K 61,521
Newcomb Jessica Principal Accounting Officer Sep 22 Open-market sale · S −700 $22.80 −$16K 66,621
Crystal Adam President, R&D Sep 01 Open-market sale · S −27,000 $22.37 −$604K 115,743
Crystal Adam President, R&D Sep 01 Exercise / conversion · M +27,000 $5.20 +$140K 142,743
Crystal Adam President, R&D Aug 03 Open-market sale · S −21,733 $27.35 −$594K 115,743
Crystal Adam President, R&D Aug 03 Open-market sale · S −5,267 $26.79 −$141K 137,476
Crystal Adam President, R&D Aug 03 Exercise / conversion · M +27,000 $5.20 +$140K 142,743
Crystal Adam President, R&D Jul 01 Open-market sale · S −7,371 $30.25 −$223K 115,743
Crystal Adam President, R&D Jul 01 Open-market sale · S −19,629 $29.34 −$576K 123,114

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support